drugset / Trial / NCT03754686
Oseltamivir Versus Paracetamol for Influenza-like Illness During the Influenza Season
RandomizedParallel-groupOpen-labelTreatment
Summary
Parallel group, investigator initiated, 1:1, open-label, non-inferiority randomized controlled trial, aiming to show that paracetamol is non-inferior to oseltamivir among patients with serious acute respiratory infection (SARI).
Timeline
- Start
- 2019-02-10
- Primary completion
- 2022-01-01
- Completion
- 2022-07-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Acetaminophen | Small molecule | — | Oral |
| Comparator | Oseltamivir | Small molecule | 30 mg | Oral |
| Comparator | Oseltamivir | Small molecule | 75 mg | Oral |